Table 1 Effects of G-Rg3 on body weights and organ weights of mice in TAA-induced chronic hepatic fibrosis model.

From: Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway

 

Dosage

Body weights (g)

Organ indices (mg/g, ×100)

 

Group

(mg/kg)

Final

Liver

Heart

Spleen

Kidney

Normal

–

44.25 ± 8.48

39.77 ± 2.20

4.80 ± 0.43

4.08 ± 0.95

14.74 ± 1.36

TAA-chronic

–

46.37 ± 3.57

50.50 ± 4.71***

4.71 ± 0.39

8.72 ± 4.26*

15.06 ± 2.02

TAA + Rg3(5 mg/kg)

50

47.19 ± 4.48

39.46 ± 5.06###

4.36 ± 0.33

4.76 ± 1.56

13.43 ± 1.41

TAA + Rg3(10 mg/kg)

50

47.29 ± 3.54

41.04 ± 1.77###

4.83 ± 0.47

4.03 ± 0.56##

15.47 ± 1.01

  1. Values are expressed as the Mean ± S.D., n = 10.
  2. *p < 0.05, ***p < 0.001 versus Normal group; ##p < 0.01, ###p < 0.001 versus TAA-chronic group.
Back to article page